Cargando…

Type 2 Diabetes Mellitus non-surgical remission: A possible mission

BACKGROUND: Remission of Type 2 Diabetes Mellitus (DM) has been observed throughout the last few years, yet factors associated with remission through non-surgical approaches are still unclear. So, the factors associated with type 2 DM remission were investigated. METHODS: Out 670 patients, 63 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Allam, Magdy M., El-Zawawy, Hanaa T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713819/
https://www.ncbi.nlm.nih.gov/pubmed/31467860
http://dx.doi.org/10.1016/j.jcte.2019.100206
_version_ 1783446938726694912
author Allam, Magdy M.
El-Zawawy, Hanaa T.
author_facet Allam, Magdy M.
El-Zawawy, Hanaa T.
author_sort Allam, Magdy M.
collection PubMed
description BACKGROUND: Remission of Type 2 Diabetes Mellitus (DM) has been observed throughout the last few years, yet factors associated with remission through non-surgical approaches are still unclear. So, the factors associated with type 2 DM remission were investigated. METHODS: Out 670 patients, 63 patients gained non-surgical remission of type 2 DM (defined according to ADA criteria), and 396 patients served as control matched for age, sex, and BMI. The records of patients who attended Alexandria University Students Hospital between the years 2015 and 2018 were reviewed retrospectively. The collected data at first visit and 1 year after remission were history, examination, HbA1c %, oral glucose tolerance test & fasting blood glucose and lipid profile and type of treatment. RESULTS: 75% of patients were females with mean age 51.5 ± 11.34 years. The mean duration of treatment till remission was 26.4 ± 33.1 months. One year after remission HbA1c & BMI were significantly decreased (P = 0.001, 0.03; respectively). However, cox proportional hazards model & ROC curve analysis showed that age < 50 years, female sex, short duration of diabetes < 5.2 years, intial HbA1c < 8.5%, HDL > 45.6 mg/dl, and initial intervention with lifestyle modification, 2000 mg metformin and 100 mg vildagliptin are the factors associated with remission. CONCLUSION: Our mission in type 2 DM female patients < 50 years with short duration of disease < 5.2 years, initial HbA1c < 8.5% and HDL > 45.6 mg/dl, is to achieve diabetes remission by intensive life style modification with daily metformin and vildagliptin.
format Online
Article
Text
id pubmed-6713819
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67138192019-08-29 Type 2 Diabetes Mellitus non-surgical remission: A possible mission Allam, Magdy M. El-Zawawy, Hanaa T. J Clin Transl Endocrinol Research Paper BACKGROUND: Remission of Type 2 Diabetes Mellitus (DM) has been observed throughout the last few years, yet factors associated with remission through non-surgical approaches are still unclear. So, the factors associated with type 2 DM remission were investigated. METHODS: Out 670 patients, 63 patients gained non-surgical remission of type 2 DM (defined according to ADA criteria), and 396 patients served as control matched for age, sex, and BMI. The records of patients who attended Alexandria University Students Hospital between the years 2015 and 2018 were reviewed retrospectively. The collected data at first visit and 1 year after remission were history, examination, HbA1c %, oral glucose tolerance test & fasting blood glucose and lipid profile and type of treatment. RESULTS: 75% of patients were females with mean age 51.5 ± 11.34 years. The mean duration of treatment till remission was 26.4 ± 33.1 months. One year after remission HbA1c & BMI were significantly decreased (P = 0.001, 0.03; respectively). However, cox proportional hazards model & ROC curve analysis showed that age < 50 years, female sex, short duration of diabetes < 5.2 years, intial HbA1c < 8.5%, HDL > 45.6 mg/dl, and initial intervention with lifestyle modification, 2000 mg metformin and 100 mg vildagliptin are the factors associated with remission. CONCLUSION: Our mission in type 2 DM female patients < 50 years with short duration of disease < 5.2 years, initial HbA1c < 8.5% and HDL > 45.6 mg/dl, is to achieve diabetes remission by intensive life style modification with daily metformin and vildagliptin. Elsevier 2019-08-16 /pmc/articles/PMC6713819/ /pubmed/31467860 http://dx.doi.org/10.1016/j.jcte.2019.100206 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Allam, Magdy M.
El-Zawawy, Hanaa T.
Type 2 Diabetes Mellitus non-surgical remission: A possible mission
title Type 2 Diabetes Mellitus non-surgical remission: A possible mission
title_full Type 2 Diabetes Mellitus non-surgical remission: A possible mission
title_fullStr Type 2 Diabetes Mellitus non-surgical remission: A possible mission
title_full_unstemmed Type 2 Diabetes Mellitus non-surgical remission: A possible mission
title_short Type 2 Diabetes Mellitus non-surgical remission: A possible mission
title_sort type 2 diabetes mellitus non-surgical remission: a possible mission
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713819/
https://www.ncbi.nlm.nih.gov/pubmed/31467860
http://dx.doi.org/10.1016/j.jcte.2019.100206
work_keys_str_mv AT allammagdym type2diabetesmellitusnonsurgicalremissionapossiblemission
AT elzawawyhanaat type2diabetesmellitusnonsurgicalremissionapossiblemission